- Home
- DRIO vs BNR Comparison
DRIO vs BNR Comparison
Compare DRIO & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- BNR
- Stock Information
- Founded
- DRIO 2011
- BNR 2014
- Country
- DRIO United States
- BNR China
- Employees
- DRIO N/A
- BNR N/A
- Industry
- DRIO Medical/Dental Instruments
- BNR Medical Specialities
- Sector
- DRIO Health Care
- BNR Health Care
- Exchange
- DRIO Nasdaq
- BNR Nasdaq
- Market Cap
- DRIO 30.5M
- BNR 29.1M
- IPO Year
- DRIO N/A
- BNR 2020
- Fundamental
- Price
- DRIO $0.71
- BNR $4.22
- Analyst Decision
- DRIO Strong Buy
- BNR
- Analyst Count
- DRIO 2
- BNR 0
- Target Price
- DRIO $2.50
- BNR N/A
- AVG Volume (30 Days)
- DRIO 118.3K
- BNR 29.7K
- Earning Date
- DRIO 08-07-2025
- BNR 08-21-2025
- Dividend Yield
- DRIO N/A
- BNR N/A
- EPS Growth
- DRIO N/A
- BNR N/A
- EPS
- DRIO N/A
- BNR N/A
- Revenue
- DRIO $28,034,000.00
- BNR $72,112,038.00
- Revenue This Year
- DRIO $13.66
- BNR $136.32
- Revenue Next Year
- DRIO $24.50
- BNR N/A
- P/E Ratio
- DRIO N/A
- BNR N/A
- Revenue Growth
- DRIO 47.20
- BNR 0.53
- 52 Week Low
- DRIO $0.50
- BNR $2.18
- 52 Week High
- DRIO $1.55
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- DRIO 52.31
- BNR 63.77
- Support Level
- DRIO $0.69
- BNR $3.06
- Resistance Level
- DRIO $0.74
- BNR $3.50
- Average True Range (ATR)
- DRIO 0.04
- BNR 0.21
- MACD
- DRIO 0.00
- BNR 0.05
- Stochastic Oscillator
- DRIO 57.32
- BNR 95.65
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.